Latest filing published 14 Jan 2014 for CERENOME, INC., €1,033.
Insider track record
No signal scores available.
Closed purchases
Based on 20 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +62.5%Entry US$8,100,000.00 · Close at T+365 US$13,162,500.00
- +53.2%Entry US$7,931,250.00 · Close at T+365 US$12,150,000.00
- +46.4%Entry US$8,296,875.00 · Close at T+365 US$12,150,000.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christopher J. Calhoun: trading record in brief
Christopher J. Calhoun discloses dealings in Cerenome, Inc. to SEC (Form 4). We count 155 filings; the first trade dates from 14 February 2006 and the latest from 10 January 2014.
Market trades split into 20 purchases (€109k) and 98 sales (€2.2M). On balance, insiders were net sellers of €2.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 31 option exercises. Since January 2014: no purchases and 15 sales on the market.
A typical purchase (the median) is worth €3,592. For 20 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 60% of cases, with a median move of +1.8%. This is a record of the past, not a forecast.
On 14 January 2014 came the latest disclosure, an open-market sale for €1,033 in Cerenome, Inc. The most recent open-market purchase was published on 20 May 2009, 6,381 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher J. Calhoun
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500 shares@ US$2.81Common StockSEC:0001140361-14-002169:0
- 2,600 shares@ US$2.82Common StockSEC:0001140361-14-002169:1
- 1,200 shares@ US$2.83Common StockSEC:0001140361-14-002169:2
- 700 shares@ US$2.84Common StockSEC:0001140361-14-002169:3
- 600 shares@ US$600.00Common StockSEC:0001140361-14-002169:4
- 1,200 shares@ US$2.86Common StockSEC:0001140361-14-002169:5
- 900 shares@ US$2.87Common StockSEC:0001140361-14-002169:6
- 2,300 shares@ US$2.88Common StockSEC:0001140361-14-002169:7
- 3,399 shares@ US$2.89Common StockSEC:0001140361-14-002169:8
- 400 shares@ US$2.90Common StockSEC:0001140361-14-002169:9
- 2,100 shares@ US$2.92Common StockSEC:0001140361-14-002169:10
- 5,803 shares@ US$2.93Common StockSEC:0001140361-14-002169:11
- 4,043 shares@ US$2.94Common StockSEC:0001140361-14-002169:12
- 1,400 shares@ US$2.95Common StockSEC:0001140361-14-002169:13
- 2,000 shares@ US$2.96Common StockSEC:0001140361-14-002169:14
- 21,105 shares0Restricted Stock (Common Stock)SEC:0001140361-13-004504:0
- 182,150 shares@ US$3.09Common StockSEC:0001140361-12-005566:0
- 40,400 shares@ US$4.00Common StockSEC:0001140361-12-005566:1
- 68,750 shares@ US$4.01Common StockSEC:0001140361-12-005566:2
- 35,400 shares@ US$4.02Common StockSEC:0001140361-12-005566:3
- 5,337 shares@ US$4.03Common StockSEC:0001140361-12-005566:4
- 7,463 shares@ US$4.04Common StockSEC:0001140361-12-005566:5
- 5,183 shares@ US$4.05Common StockSEC:0001140361-12-005566:6
- 7,595 shares@ US$4.06Common StockSEC:0001140361-12-005566:7
- 4,305 shares@ US$4.07Common StockSEC:0001140361-12-005566:8
25 of 137 declarations
